Bengaluru-based Lumov has raised Rs 10 crore ($1.2 million) in a seed funding round led by Incubate Fund Asia.
Additionally, QRG Investments and Holdings (Havells Family Office), IIMA Ventures, SIDBI, and several angel investors—including Ashish Gupta of Helion Advisors, Saket Narang of Steinberg India, Abhishek Goyal of Tracxn, Arjun Vaidya of Indian Silicon Valley, and Mapaex Family Office—participated in the round.
Moreover, the funding will support Lumov’s expansion, strengthen its product development pipeline, and deepen its collaboration with orthopedic surgeons across India. The startup plans to scale operations in Delhi NCR, Hyderabad, and Mumbai while enhancing its manufacturing and sales capabilities. It currently employs a core team of 15 members and expects significant hiring across product development, sales, and operations.
Founded by IIT Kharagpur and Harvard Business School alumni Saumaric Dangwal and Ankit Gupta, Lumov designs and manufactures orthopedic recovery and rehabilitation products for post-surgical care, long-term mobility support, and lifestyle-driven pain management. Furthermore, specialists from hospital chains such as Manipal, Apollo, Sakra, and AIG collaborate with Lumov to develop its orthoses and recovery aids.
The products focus on clinical effectiveness, patient comfort, and India-specific anatomy and climate requirements, thereby aiming to improve compliance and recovery outcomes.
Saumaric Dangwal and Ankit Gupta said, “India is in the midst of an orthopaedic health crisis. While advances in diagnostics and care delivery are improving outcomes, we are building the physical product layer: premium, high-quality orthotics, rehabilitation aids, and pain-management solutions designed to accelerate recovery and help people live pain-free, active lives.”
Furthermore, Rajeev Ranka, Partner at Incubate Fund Asia, said, “The musculoskeletal (MSK) care category, particularly in post-surgical recovery, rehabilitation, and lifestyle-driven pain relief, is poised for significant innovation. Lumov’s surgeon-led approach, Saumaric and Ankit’s profound market understanding, and integration of modern design principles instill high confidence that they can emerge as a category-defining company in MSK care.”
